New Delhi: The government’s decision to introduce COVID vaccination to children in the age group of 15-18 is based on a scientific evaluation of local as well as global data, which shows that 75% of COVID deaths among children in the same age group during the last two years. happened in class. , National Technical Advisory Group on Immunization (NTAGI) President NK Arora said.
“Assessment of data for the last two years shows that 75% of all deaths among children – below 18 years – are due to Covid-19 between 15-18 years. This is also the age when children interact more with adults. Vaccination is given in this way in a phased manner around the world. We have also vaccinated on the same scientific principles. Our own data suggest that complications in children under 18 years of age are concentrated in the age group of 15-18 years. This is the reason for giving priority to this age group for vaccination in children,” Arora said.
He stressed that vaccination of this age group will also reduce the risk of transmission through these youths to their family members. The remarks came after some experts expressed concern over the government’s decision to introduce immunization of children in the 15-18 age group, saying the disease is mild in children.
According to Arora, the disease is very mild in children below the age of 10 years and the chances of seriousness in them are also very less. However, in people above the age of 12, the effect of this disease is similar to that of most adults. He also said that 10-15% of children between 15 and 18 years have comorbidities.
“Assessment of data for the last two years shows that 75% of all deaths among children – below 18 years – are due to Covid-19 between 15-18 years. This is also the age when children interact more with adults. Vaccination is given in this way in a phased manner around the world. We have also vaccinated on the same scientific principles. Our own data suggest that complications in children under 18 years of age are concentrated in the age group of 15-18 years. This is the reason for giving priority to this age group for vaccination in children,” Arora said.
He stressed that vaccination of this age group will also reduce the risk of transmission through these youths to their family members. The remarks came after some experts expressed concern over the government’s decision to introduce immunization of children in the 15-18 age group, saying the disease is mild in children.
According to Arora, the disease is very mild in children below the age of 10 years and the chances of seriousness in them are also very less. However, in people above the age of 12, the effect of this disease is similar to that of most adults. He also said that 10-15% of children between 15 and 18 years have comorbidities.
,